Fieldpoint Private Securities’s Immunomedics Inc IMMU Stock Holding History

Fieldpoint Private Securities’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,701	Closed	-$485K	–	1579
2020 Q3	$485K	Sell	5,701 -1,952	-26%	-$98.7K	0.14%	167
2020 Q2	$271K	Sell	7,653 -14,497	-65%	-$424K	0.09%	204
2020 Q1	$299K	Sell	22,150 -287	-1%	-$4.83K	0.12%	182
2019 Q4	$475K	Buy	22,437 +16,300	+266%	+$288K	0.14%	165
2019 Q3	$81K	Sell	6,137 -530	-8%	-$7.79K	0.03%	331
2019 Q2	$92K	Buy	+6,667	New	+$100K	0.03%	343

Fieldpoint Private Securities's IMMU Position: Q4 2020 in Review

Fieldpoint Private Securities sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 5,701 shares — an estimated $485K sold.

Fieldpoint Private Securities first reported a position in IMMU in Q2 2019 and held it in 6 quarters. The position peaked at $485K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Fieldpoint Private Securities reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Fieldpoint Private Securities sold 5,701 Immunomedics Inc shares in Q4 2020, an estimated $485K.
Fieldpoint Private Securities first reported a position in Immunomedics Inc in Q2 2019 and held it in 6 quarters.
Fieldpoint Private Securities's Immunomedics Inc position peaked at $485K in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Fieldpoint Private Securities's 13F filing for Q4 2020, filed 28 Jan 2021.